FibroSIGHT™ Plus: Precision in Fibrosis Assessment with AI-based Analysis

Efruxifermin improved digital pathology and noninvasive fibrosis measures in participants with MASH and advanced fibrosis or compensated cirrhosis: analysis of the HARMONY and SYMMETRY phase 2b trials

View Poster